Industry Reports
Pivotal Therapeutics reports third quarter 2012 financial results
Pivotal Therapeutics Inc. , a specialty pharmaceutical company with a focus on cardiovascular disease and overall health today announced its financial results and...
Press Releases
Exact Sciences to participate in Canaccord Genuity Medical Technology & Diagnostics Forum
Exact Sciences Corp. today announced that it will present at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York. ...
Press Releases
Exact Sciences to participate in Canaccord Genuity Medical Technology & Diagnostics Forum
Exact Sciences Corp. today announced that it will present at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York. ...
News
Patient’s own immune cells may blunt viral therapy for brain cancer
Doctors now use cancer-killing viruses to treat some patients with lethal, fast-growing brain tumors. Clinical trials show that these therapeutic viruses are safe...
Press Releases
ERYTECH Pharma Signs Licensing and Distribution Agreement with Orphan Europe for GRASPA® in Europe
ERYTECH Pharma, a late stage biopharmaceuticals company focused on orphan oncology and rare diseases, announced today that it has entered into a definitive...
News
Discovery offers new treatment for epilepsy
New drugs derived from components of a specific diet used by children with severe, drug-resistant epilepsy could offer a new treatment, according to...
Press Releases
Genzyme’s Once-Daily, Oral AUBAGIO® Approved in Australia for Treatment of Relapsing Multiple Sclerosis
Genzyme, aSanofi company, announced today that the Australian Therapeutic Goods Administration (TGA) has approved AUBAGIO® (teriflunomide) 14 mg as a new once-daily, oral...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read